Pharmaceutical impurity testing and quantification is essential for addressing the purity, safety and quality of Active Pharmaceutical Ingredients, excipients, other drug substances and finished drug products. The impurities in finished dosage form can arise from possible contamination in multiple sources as reagents, solvents, catalysts, excipients, degradation products, intermediaries or leachables; and can be either organic or inorganic. Since these impurities are present at extremely low levels and often in complex matrices; their detection requires highly sensitive and specific methods of detection.
At VIMTA, we perform pharmaceutical impurity testing for new drug substances as well as products, and are skilled in performing analysis even with difficult matrices. Our laboratories are GMP compliant, and our lab for ultra-trace analysis is equipped with state of the art instrumentation thus helping overcome challenges associated with low detection levels.